“Kraven the Hunter” Weekend Box Office Collection Compared to Other Movies in Sony’s Spider-Man Universe

Sony’s Kraven the Hunter finally hit theaters, bringing one of Spider-Man’s fiercest villains to life. Played by Aaron Taylor-Johnson, this R-rated, action-packed film had high hopes for success. However, its box office numbers tell a very different story.

The movie didn’t just struggle—it flopped hard. With a production budget as big as its action scenes, Kraven needed a strong opening weekend to stay in the game. Sadly, the results suggest that this might be the final nail in the coffin for Sony’s Spider-Man Universe (SSU).

Sony has been building its Spider-Man spin-off franchise for years, with films like Venom and Morbius. While some were hits (Venom), others were big disappointments (Morbius and Madame Web).

Now, with Kraven the Hunter, Sony hoped to turn things around. But the numbers show that things didn’t go as planned. Let’s dive into the box office performance and see how Kraven the Hunter compares to Sony’s other Marvel movies.

Kraven the Hunter’s overall box office performance

Kraven the Hunter’s opening weekend numbers were disappointing, to say the least. The film earned just $11 million in the U.S. and Canada during its first three days. Internationally, it made another $15 million, bringing its total worldwide opening to $26 million (per Box Office Mojo).

For a movie that cost $110–$130 million to produce (via Movie Web), this is a terrible start. Most films need to make at least double their budget to break even. Kraven’s $26 million opening weekend makes that goal seem almost impossible.

Opening weekend is everything in Hollywood. Sadly, Kraven stumbled out of the gate. Not even an R-rating, gnarly fight scenes, or Aaron Taylor-Johnson’s charisma could save it. To compare, even Sony’s Morbius—widely criticized and joked about—did better. Even Madame Web looks like a box-office heavyweight next to Kraven.

So, the film just didn’t click with audiences, and there are a few reasons why. First off, Kraven isn’t exactly a household name. Unlike Venom, who’s got a massive fan base, Kraven’s name doesn’t carry the same weight.

Then there’s the marketing—it didn’t do much to hype the movie or make it feel like a must-watch. Add to that Sony’s shaky track record with their Spider-Verse movies. After flops like Morbius and mixed reviews for Venom: The Last Dance, audiences may have lost faith in Sony’s Spider-Verse.

Kraven the Hunter had the chance to turn things around, but honestly, it looks like it might be too little, too late. Either way, it’s a rough start for a movie that needed blockbuster energy to survive.

How Kraven the Hunter compares to other Sony Marvel movies

Let’s take a look at how Kraven the Hunter stacks up against Sony’s other Marvel movies. We’ll start with Venom (these numbers are from Box Office Mojo). In 2018, Venom debuted with $80 million domestically, followed by $200+ million worldwide in its first weekend.

Its sequel, Venom: Let There Be Carnage, did even better, with $90 million domestically in its opening. Even Venom: The Last Dance (while not as strong as its predecessors) pulled $51 million in its debut weekend. But Kraven is not even close.

Even when we stack Kraven up against some of Sony’s lesser films, the numbers aren’t in its favor. For instance, let’s talk about Morbius. Yep, even that meme-fueled film outperformed Kraven. With $39 million in its first three days, Morbius laughed its way to $167 million worldwide (via Box Office Mojo).

Madame Web, another SSU outlier, at least clawed its way to $15 million domestically, earning $100 million worldwide (per BOM). Kraven had an edge with its R-rating and violent action scenes, but audiences still gave it the cold shoulder. Compared to these hits, its $11 million domestic opening is embarrassingly low.

The future of Sony’s Spider-Verse

Before Kraven the Hunter was released, there were rumors that it could be the last movie in Sony’s Spider-Verse (per TIME). With these box office numbers, that possibility seems even more likely. Venom’s success aside, the studio can’t seem to replicate its formula.

The other movies—Morbius, Madame Web, and now Kraven the Hunter—have all been box office disappointments. Without a strong hit to keep the franchise alive, it’s hard to imagine Sony moving forward with more Spider-Man spin-offs.

For now, it seems like Sony will focus on other Spider-Man-related projects, like Spider-Man: Beyond the Spider-Verse and the Marvel Cinematic Universe’s Spider-Man 4. These films have a much better chance of success than the struggling Spider-Verse spin-offs.

Kraven the Hunter is currently screening in theatres!